DC2505: Creating Your Teaching Portfolio for Promotion

Tuesday, March 4, 2025, 9:00 AM - 10:30 AM, UWMC- Montlake

AMA PRA Category 1 Credits™ (1.50 hours), ABS CME (1.50 hours), Non-Physician (1.50 hours)


The UW School of Medicine Office of Faculty Affairs hosts annual virtual career development workshops. These workshops focus on building skills and sharing tools that faculty can use to advance their careers and promotional oppotunities in academic medicine. Current Faculty Career Development workshops focus on two skills critical to faculty advancement; building a strong CV and creating a teaching portfolio.

1. 1) Understand how the Teaching Portfolio is part of the promotions process but differs from the CV.2) Identify what information to include and emphasize in a Teaching Portfolio.3) Identify and review examples of Teaching Portfolio content beyond teaching and publications such as teaching philosophy statements, educational administration, and other teaching activities. 4) Understand and identify Teaching Portfolio requirements for individual based on Department and faculty pathway. 5) Identify timeline and resources needed to create and maintain a Teaching Portfolio.

Accreditation with Commendation: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation: The University of Washington School of Medicine designates this Live Activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation of Relevant Financial Relationships

University of Washington School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of an accredited activity, including faculty, planners, reviewers or others in control of content are required to disclose all relevant financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the start of the activity.